Drugs

Inhibiting Costimulatory Activation of T Cells: A Viable Treatment Option For Rheumatoid Arthritis?
pp. 1-9(9)
Author: Pollard, Louise C.

Squalene Synthase Inhibitors: Clinical Pharmacology and Cholesterol-Lowering Potential
pp. 11-16(6)
Authors: Charlton-Menys, Valentine; Durrington, Paul N.

Practical Issues and Challenges in the Diagnosis and Treatment of Pulmonary Sarcoidosis
pp. 17-26(10)
Author: Jindal, Surinder K.

Serotonergic Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity
pp. 27-55(29)
Authors: Halford, Jason C.G.; Harrold, Joanne A.; Boyland, Emma J.; Lawton, Clare L.; Blundell, John E.

Therapeutic Applications of Sildenafil Citrate in the Management of Paediatric Pulmonary Hypertension
pp. 57-73(17)
Authors: Leibovitch, Leah; Matok, Ilan; Paret, Gideon

Ocular Adverse Effects Associated with Systemic Medications: Recognition and Management
pp. 75-93(19)
Authors: Santaella, Ricardo M.; Fraunfelder, Frederick W.

Fixed-Dose Combination Lercanidipine/Enalapril
pp. 95-106(12)
Authors: Hair, Philip I.; Scott, Lesley J.; Perry, Caroline M.

Fixed-Dose Combination Lercanidipine/Enalapril: A Viewpoint by Nicolás R. Robles
pp. 107-108(2)
Authors: Robles, Nicolás R.

Fixed-Dose Combination Lercanidipine/Enalapril: A Viewpoint by Roland Asmar
pp. 107-108(2)
Author: Asmar, Roland

Limaprost
pp. 109-118(10)
Authors: Tracy Swainston Harrison,; Plosker, Greg L.

Limaprost: A Viewpoint by Akira Dezawa
pp. 119-120(2)
Author: Dezawa, Akira

Limaprost: A Viewpoint by Shin-Ichi Konno
pp. 119-120(2)
Author: Konno, Shin-ichi

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus
pp. 121-153(33)
Authors: Keating, Gillian M.; Croom, Katherine F.